Committees : Epsom St Helier NDAIG
You are here : Home > Committees : Epsom St Helier NDAIG
Committee Types
Please select an organisation name from the list below to view associated profiles and decisions.
Committee
- ASPH DTC
- East Surrey CCG Medicines Programme Board
- East Surrey MOG
- Epsom St Helier NDAIG
- ESCCG sub-committee of North Place Alliance Clinical Strategy Committee (formerly Clinical Executive
- Guildford and Waverley MOG
- Medicines Optimisation Operational Group (MOOG)
- Not Set
- NW Surrey Medicines Optimisation Group
- Primary Care Medicines Optimisation Clinical reference Group (PCMOCRG)
- RSFT DTC
- SASH DTC
- Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
- Surrey Downs CCG Prescribing Leads Meeting
- Surrey Downs MOG
- Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
- Surrey Heartlands Medicines Optimisation Board (MOB)
- Surrey Heartlands Medicines Safety Committee (MSC)
- Surrey Medicines Commissioners Group
Trust
Profiles (0)
No records returned.
Committee Recommendations (3)
02 Oct 19
SDCCG / Epsom & St Helier - LOCAL RECOMMENDATION
Epsom & St Helier have produced guidance on the identification and management of Polymyalgia Rheumatica for the GPs of Surrey Downs CCG
11 Oct 17
SDCCG and EPSOM ST HELIER - RED STATUS
The New Drugs & Interface Committee agreed that Ferracru (Ferric maltol) is available to be prescribed in the Trust by consultant gastroenterologists (or gastroenterology Specialist registrars under the guidance of gastro consultants) in IBD patients only. It has a place as an oral iron therapy in patients intolerant to at least one oral ferrous iron salt as an alternative to iv iron therapy. It is usually prescribed for 2-3 months from secondary care
The New Drugs & Interface Committee agreed that Ferracru (Ferric maltol) is available to be prescribed in the Trust by consultant gastroenterologists (or gastroenterology Specialist registrars under the guidance of gastro consultants) in IBD patients only. It has a place as an oral iron therapy in patients intolerant to at least one oral ferrous iron salt as an alternative to iv iron therapy. It is usually prescribed for 2-3 months from secondary care
20 Feb 13
Shared care documentation approved